News

Press Release

October 17, 2023

Albert Labs Welcomes Dr. Shabir Hasham to Board of Directors

October 17th, 2023 - VANCOUVER, BRITISH COLUMBIAAlbert Labs International Corp. (CSE: ABRT], the "Company" or…

Albert Labs

Love0

Press Release

September 5, 2023

Albert Labs Management and Board of Director Announcement

September 5th, 2023 - VANCOUVER, BRITISH COLUMBIA Albert Labs International Corp. (Albert Labs (CSE: ABRT)…

Albert Labs

Love0

Press Release

May 2, 2023

Albert Labs Receives preliminary acceptance of 35 Novel Inventive Claims for Patent Protected Manufacturing Technology

May 2nd, 2023 - VANCOUVER, BRITISH COLUMBIA Albert Labs International Corp. (CSE: ABRT) (the "Company" or…

Albert Labs

Love0

Press Release

April 26, 2023

Expansion of Drug Discovery and a Promising Pipeline

Highlights Albert Labs announces expansion of an exciting drug pipeline, broadening the Company’s product portfolio…

Albert Labs

Love0

Press Release

November 23, 2022

Albert Labs Announces Private Placement

Albert Labs, today announced that it has received conditional approval for the listing of its…

Albert Labs

Love0

Press Release

November 17, 2022

Letter of Intent (LOI) for First-In-Human studies with iNGENū CRO

Albert Labs, today announced that it has received conditional approval for the listing of its…

Albert Labs

Love0

Press Release

October 25, 2022

Albert Labs Provides Corporate Update

Albert Labs, today announced that it has received conditional approval for the listing of its…

Albert Labs

Love0

Industry News

October 22, 2022

Psychedelic Therapy isn’t Fringe Anymore

Albert Labs

Love0

Industry News

October 22, 2022

Can Psychedelics Cure?

Albert Labs

Love0

Industry News

October 22, 2022

The Lancet Commission on Ending Stigma and Discrimination in Mental Health

Albert Labs

Love0

Albert Labs Welcomes Dr. Shabir Hasham to Board of Directors

Albert Labs Management and Board of Director Announcement

Albert Labs Receives preliminary acceptance of 35 Novel Inventive Claims for Patent Protected Manufacturing Technology

Expansion of Drug Discovery and a Promising Pipeline

Albert Labs Announces Private Placement

Letter of Intent (LOI) for First-In-Human studies with iNGENū CRO

Albert Labs Provides Corporate Update

Psychedelic Therapy isn’t Fringe Anymore

Can Psychedelics Cure?

The Lancet Commission on Ending Stigma and Discrimination in Mental Health

Innovative mental health medicines for patients with unmet needs.

Navigate

About

Team

Contact

Connect

info@albertlabs.com

Get in touch

About Salient